Sign In
Buy SIBN
$15.84
+0.630 (+4.14%)
At Close: Jun 18, 2026
SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation
08:30am, Thursday, 10'th Oct 2024
SANTA CLARA, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to providing surgical solutions for sacropelvic disorders,
Wall Street Analysts Think Si-Bone (SIBN) Could Surge 40.3%: Read This Before Placing a Bet
10:55am, Monday, 26'th Aug 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 40.3% in Si-Bone (SIBN). While the effectiveness of this highly sought-after metric is questionable, the positi
SI-BONE (SIBN) Receives FDA Nod for Its TNT Implant System
09:20am, Monday, 26'th Aug 2024
SI-BONE (SIBN) receives FDA 510(k) clearance for its iFuse TORQ TNT implant system, followed by a Breakthrough Device Designation award by the FDA.
SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024
04:30pm, Thursday, 22'nd Aug 2024
SANTA CLARA, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be parti
SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System
08:30am, Tuesday, 20'th Aug 2024
SANTA CLARA, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to providing surgical solutions for sacropelvic disorders
Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 64.45%: Here's is How to Trade
11:00am, Thursday, 08'th Aug 2024
The consensus price target hints at a 64.5% upside potential for Si-Bone (SIBN). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate
SI-BONE To Present at Canaccord Genuity 44th Annual Growth Conference on August 14, 2024
08:30am, Tuesday, 06'th Aug 2024
SANTA CLARA, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will be participating in th
SI-BONE, Inc. (SIBN) Q2 2024 Earnings Call Transcript
11:23pm, Monday, 05'th Aug 2024
SI-BONE, Inc. (NASDAQ:SIBN ) Q2 2024 Earnings Conference Call August 5, 2024 4:30 PM ET Company Participants Saqib Iqbal - Senior Director of Investor Relations Laura Francis - Chief Executive Officer
Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates
06:55pm, Monday, 05'th Aug 2024
Si-Bone (SIBN) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.26. This compares to loss of $0.30 per share a year ago.
SI-BONE, Inc. Reports Financial Results for the Second Quarter 2024
04:09pm, Monday, 05'th Aug 2024
Increases 2024 revenue guidance to $165 million - $167 millionExpects to achieve positive Adjusted EBITDA in Fourth Quarter 2024
7 Leading MedTech Stocks for Next-Gen Health Solutions
02:30pm, Wednesday, 31'st Jul 2024
While technology lately has been framed in the context of computer hardware or software, it can also apply to the broader field of medicine. Therefore, investors should consider the viable field of Me
SI-BONE To Report Second Quarter 2024 Financial Results on August 5, 2024
04:09pm, Monday, 15'th Jul 2024
SANTA CLARA, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced
SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024
04:09pm, Wednesday, 05'th Jun 2024
SANTA CLARA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced
SANTA CLARA, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic ana
SI-BONE, Inc. (SIBN) Q1 2024 Earnings Call Transcript
08:47pm, Monday, 06'th May 2024
SI-BONE, Inc. (NASDAQ:SIBN ) Q1 2024 Results Conference Call May 6, 2024 4:30 PM ET Company Participants Saqib Iqbal - Senior Director, Investor Relations Laura Francis - Chief Executive Officer Anshu
